|  | 
              
  
              
              Open Access  
Copyright: The authors. This article is an open access 
article licensed under the terms of the Creative Commons Attribution License 
(http://creativecommons.org/licenses/by/2.0) which permits unrestricted use, 
distribution and reproduction in any medium, provided the work is properly 
cited. 
 
              
              
              Research 
(Published 
online : 12-07-2013)17.
Biochemical, histopathological and ultra structural profile after pulsed water 
medication of enrofloxacin in broiler chickens 
- 
Veerapandian Sureshkumar, Ghadevaru Sarathchandra and Jayaramachandran Ramesh
 
Vet World. 2013; 6(9):
  668-673 
                
              doi: 
              10.14202/vetworld.2013.668-673 
                
  
  
    
                        
 
              Abstract 
 Aim:
              A pharmacological study was undertaken to evaluate the safety 
              and adverse effects of enrofloxacin administration in broiler 
              chickens by assessing the serum biochemical parameters, associated 
              histopathological and ultra structural changes in liver and 
              kidney. 
              Materials and Methods: Birds in the treatment group were 
              administered with enrofloxacin at the recommended therapeutic dose 
              10mg/kg body weight via drinking water for five successive days, 
              while the control group (untreated group) received non medicated 
              water. Serum biochemical parameters viz., total protein, albumin, 
              lactate dehydrogenase, alkaline phosphatase, creatine kinase, 
              lipase, triglyceride, gamma glutamyl transferase, urea, 
              uric acid and creatinine were estimated at 24hour and 48hour 
              intervals during the dosing and withdrawal periods, respectively. 
              Liver and kidney tissue samples collected from 1, 3, 5, 7, and 9 
              days post treatment groups were subjected to histopathological and 
              ultrastructural examinations. 
              Results: There was no significant change (p>0.05) in total 
              protein, albumin, lactate dehydrogenase, alkaline phosphatase, 
              creatine kinase, lipase, triglyceride and urea levels in the 
              enrofloxacin administered broiler chickens at all the time points 
              evaluated. However, a significant increase (p<0.05) in gamma
              glutamyl transferase, uric acid and creatinine levels were 
              observed after the 4th
              dose of the enrofloxacin and on day 1 post 
              treatment. During the withdrawal period, the elevated levels 
              declined gradually and showed the trend towards control values as 
              evidenced by a statistically insignificant difference on 3, 5, 7 
              and 9 days post treatment when compared to that of control group. 
              These biochemical changes were substantiated by histopathological 
              and ultrastructural changes elicited in liver and kidney. 
              Conclusion: The reversible trend observed in serum biochemical 
              parameters, histopathological and ultra structural alterations in 
              liver and kidney during the withdrawal period suggests that 
              enrofloxacin is safe if administered to broiler chickens at the 
              recommended therapeutic dose and if the stipulated withdrawal 
              period is strictly adhered to. 
              Keywords: biochemical parameters, broiler chickens, 
              enrofloxacin, histopathology, ultrastructural, veterinary 
              pharmacovigilance 
 
              References 
 
                
                  | 1. Johnston, A.M. (1998) Use of antimicrobial drugs in 
                  veterinarypractice. Br. Med. J. 317: 665-667. http://dx.doi.org/10.1136/bmj.317.7159.665
 PMid:9728002 PMCid:PMC1113841
 |  
                  |  |  
                  | 2. Prescott, J.F., Baggot, J.D. and Walker, R.D. (2000) 
                  Fluoroquinolones, In: Prescott, J.F.,Baggot, J.D. and Walker, 
                  R.D., editors, Antimicrobial Therapy in Veterinary Medicine, 
                  3rd edition. Ames: Iowa State University Press. 315-339. |  
                  |  |  
                  | 3. Martinez, M., McDermontt, P. and Walker, R. (2006) 
                  Pharmacology of the fluoroquinolones: a perspective for the 
                  use in domestic animals. Vet. J. 172: 10-28. http://dx.doi.org/10.1016/j.tvjl.2005.07.010
 PMid:16154368
 |  
                  |  |  
                  | 4. Papich, M.G. and Riviere, J.E. (2009) Fluoroquinolone 
                  antibacterialdrugs. In: Riviere, J.E. and Papich, M.G., 
                  editors, Veterinary Pharmacology and Therapeutics. 9th 
                  edition. Wiley-Blackwell, Iowa State University Press, USA. 
                  983-1011. |  
                  |  |  
                  | 5. Anderson, A.D., Nelson, J.M., Rossiter, S. and Angulo, F.J. 
                  (2003) Public health consequences of use of antimicrobial 
                  agents in food animals in the United States. Microb Drug 
                  Resist. 9: 373-379. http://dx.doi.org/10.1089/107662903322762815
 PMid:15000744
 |  
                  |  |  
                  | 6. Wagman, A.S. and Wentland, M.P. (2007) Quinolone 
                  antibacterial agents. Comprehensive Medicinal Chemistry II, 
                  Chapter 7, 567-596. |  
                  |  |  
                  | 7. Taccetti, G., Campana, S., Neri, A., Boni, V. and Festini, 
                  F. (2008) Antibiotic therapy against Pseudomonas aeruginosa in 
                  cystic fibrosis. J. Chemother. 20: 166-169. PMid:18467240
 |  
                  |  |  
                  | 8. Kordick, D., Papich, M. and Breitschwerdt, E. (1997) 
                  Efficacy of enrofloxacin or doxycycline for treatment of 
                  Bartonella henselae or Bartonella clarridgeiae infection in 
                  cats. Antimicrob Agents Chemother. 41: 2448-2455. PMid:9371348 PMCid:PMC164143
 |  
                  |  |  
                  | 9. Todorov, T. (2004) A preclinical study on Biofloxavet C (enrofloxacin) 
                  tolerance in cats. Bulg J Vet Med. 7: 239-244. |  
                  |  |  
                  | 10. Shoorijeh, S.J., Tamadon, A., Vahedi, M. and Behzadi, M.A. 
                  (2012) Hematological and biochemical alterations due to over 
                  dosage of enrofloxacin in cats. Pak Vet J. 32: 73-76. |  
                  |  |  
                  | 11. Hooper, D.C. and Wolfson, J.S. (1985) The fluoroquino- 
                  lones: pharmacology, clinical uses, and toxicities in human. 
                  Antimicrob. Agents Chemother. 28: 716-721. http://dx.doi.org/10.1128/AAC.28.5.716
 PMid:2936302 PMCid:PMC176369
 |  
                  |  |  
                  | 12. Sureshkumar, V., Sarathchandra, G., Ramesh, J., Vairamuthu, 
                  S., Thejomoorthy, P. and Hariharan, P. (2012) The effect of 
                  enrofloxacin administration on haematological profile in 
                  broiler chicken – A safety pharmacology study. The Indian 
                  Journal of Field Veterinarians. 8: 20-24. |  
                  |  |  
                  | 13. Sureshkumar, V., Saratchandra, G. and Ramesh, J. (2013) 
                  Effect of enrofloxacin on Zootechnical performance, behaviour 
                  and immunohistopathological response in broiler chicken. 
                  Veterinary World. 6:337-342 http://dx.doi.org/10.5455/vetworld.2013.337-342
 |  
                  |  |  
                  | 14. Patel, J.H., Varia, R.D., Patel, U.D. and Vihol, P.D. 
                  (2009) Safety level of levofloxacin following repeated oral 
                  adminis- tration in White Leghorn layer birds. Vet. World. 2: 
                  137-139. |  
                  |  |  
                  | 15. Knoll, U., Glunder, G. and Kietzmann, M. (1999) 
                  Comparative study of the plasma pharmacokinetics and tissue 
                  concentrations of danofloxacin and enrofloxacin in broiler 
                  chickens. J. Vet. Pharmacol. Therap., 22: 239-246. http://dx.doi.org/10.1046/j.1365-2885.1999.00217.x
 PMid:10499235
 |  
                  |  |  
                  | 16. Charleston, B., Gate, J.J., Aitken, I.A., Stephan, B. and 
                  Froyman, R. (1998) Comparison of the efficacies of three 
                  fluoroquinolone antimicrobial agents, given as continuous or 
                  pulsed-water medication, against Escherichia coli infection in 
                  chickens. Antimicrob.Agents Chemother. 42:83-87. PMid:9449265 PMCid:PMC105460
 |  
                  |  |  
                  | 17. Snedecor, G.W. and Cochran, W.G. (1994) Statistical 
                  methods, 8th Edn., Ames: Iowa State University Press. |  
                  |  |  
                  | 18. Bancroft, J.D. and Gamble. M. (2008) Theory and practice 
                  of histological techniques. 6th edition. Churchill 
                  Livingstone, Philadelphia. |  
                  |  |  
                  | 19. Elkholy, H.M., Elkomy, A.A., Awidat, S.K. and Elmajdoub, 
                  A.A. (2009) Tissue and egg residues and adverse effect of two 
                  oral enrofloxacin preparations; BaytrilŪ and EnrotrylŪ. Global 
                  Veterinaria, 3: 363-368. |  
                  |  |  
                  | 20. Moustafa, A., Baset Abdel, I., El Mashad, A. and Tantawy, 
                  A. (1998) Pathological studies on enrofloxacin and its 
                  residues in broiler's chickens. Egypt. J. Comp. Pathol. Clin. 
                  Pathol. 11: 57-66. |  
                  |  |  
                  | 21. Tras, B., Maden, M., Bas, A.L., Elmas, M., Yazar, E. and 
                  Civelek, T. (2001) Investigation of biochemical and 
                  haematological side-effects of enrofloxacin in dogs. J. Vet 
                  Med A. 48: 59-63. http://dx.doi.org/10.1046/j.1439-0442.2001.00332.x
 |  
                  |  |  
                  | 22. Davoren, P. and Mainstone, K. (1993) Norfloxacin-induced 
                  hepatitis. Med J Aust.159: 423-424. PMid:8377697
 |  
                  |  |  
                  | 23. Jones, S.E. and Smith, R.H. (1997) Quinolones may induce 
                  hepatitis. Br Med J. 314: 869-870. http://dx.doi.org/10.1136/bmj.314.7084.869
 PMid:9093098 PMCid:PMC2126221
 |  
                  |  |  
                  | 24. Ellakany, H.F., Abu El-Azm, I.M., Bekhit, A.A. and Shehawy, 
                  M.M. (2007) Studies on the effects of enrofloxacin overdose on 
                  different health parameters in broiler chickens BS. Vet. Med. 
                  J. 5th Scientific Conference, 176-186. |  
                  |  |  
                  | 25. Shawky, M.A., Abdel-Baset, I., El-Mashad and Tantawy, A.A. 
                  (1998) Pathological studies on enrofloxacin and its residues 
                  in broiler chickens. Egypt. J. Comp. Pathol. Clin. Pathol. 11: 
                  57-66. |  
                  |  |  
                  | 26. Vaccaro, E., Giorgi, M., Longo, V., Mengozzi, G. and 
                  Cervasi, P.G. (2003) Inhibition of cytochrome P450 enzymes by 
                  enrofloxacin in the sea bass (Dicentrarchus labrax). Aquat. 
                  Toxicol.62: 27-33. http://dx.doi.org/10.1016/S0166-445X(02)00064-4
 |  
                  |  |  
                  | 27. El Daly, A.A.A. (2011) The protective effect of green tea 
                  extract against enrofloxacin action on the rat liver; 
                  histological, histochemical and ultrastructural studies. J. 
                  Am. Sci. 7: 669- 679. |  |  |